CGNX Cognex (CGNX) Insider Trading, Ownership & Congress Trades
Industrials · Industrial instruments for measurement, display, and control · CIK 0000851205
Form 144 · 1
Insider buyers, 180 days
0
House members buying, 1 year
0
STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
401
13F, latest reported quarter
Conversions, 180 days
25
Codes C/M, not in net · $11.2M priced
What the filings say about CGNX
Insiders, 180 days
-$16.6M net sold
4 sellers · 0% of sales under a 10b5-1 plan
Planned sales (Form 144), 90 days
$1.6M
1 notice
Cognex insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, COGNEX CORP insiders sold a net $16.6M of stock across 73 Form 4 purchases and sales, with no insider buying. Source: SEC Form 4 filings, as of 2026-10-28.
Insider
Filed
Shares
Value
Since filing
Context
- First Form 4 purchase or sale (code P or S) here by this insider on our record.
- The trade is 8.3% of the 19,246 shares held after it.
- No other insider sold within 30 days.
- 401 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: CEO & President Moschner Matthew sold about $104.6K of CGNX on Aug 11, 2026; 401 funds added in the latest 13F quarter.Context
- First Form 4 purchase or sale (code P or S) here by this insider on our record.
- The trade is 20.8% of the 19,246 shares held after it.
- No other insider sold within 30 days.
- 401 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: CEO & President Moschner Matthew sold about $261.4K of CGNX on Aug 11, 2026; 401 funds added in the latest 13F quarter.Context
- First Form 4 purchase or sale (code P or S) here by this insider on our record.
- The trade is 20.8% of the 19,246 shares held after it.
- No other insider sold within 30 days.
- 401 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: CEO & President Moschner Matthew sold about $254.5K of CGNX on Aug 11, 2026; 401 funds added in the latest 13F quarter.Context
- First Form 4 purchase or sale (code P or S) here by this insider on our record.
- The trade is 36.4% of the 19,246 shares held after it.
- No other insider sold within 30 days.
- 401 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: CEO & President Moschner Matthew sold about $445.3K of CGNX on Aug 11, 2026; 401 funds added in the latest 13F quarter.Context
- First Form 4 purchase or sale (code P or S) here by this insider on our record.
- The trade is 76.8% of the 10,884 shares held after it.
- No other insider sold within 30 days.
- 401 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: CEO & President Moschner Matthew sold about $532.0K of CGNX on Aug 11, 2026; 401 funds added in the latest 13F quarter.73 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Seven facts, ranked against the sector ·
Rank is not a forecast
Insiders
net -$16.6M over 180 days
-$1.6M over 90 days
below 84% of Industrials
Congress
no House purchase disclosed in the last 12 months
Funds
401 funds bought in last quarter
more than 83% of Industrials
Revenue
+8.7% year over year
more than 64% of Industrials
Margin
11.5% net margin
more than 74% of Industrials
Buybacks
$105.2M repurchased, FY to 2026-07-05
more than 60% of Industrials
Short interest
3.9% of the float short (float per yahoo 2026-10-27) · 3.1 days to cover · settled 2026-10-15
more than 59% of Industrials
What changed in the last 30 days
Nothing new filed in the last 30 days
Watch CGNX
A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.
The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
+16.4%12M
Insider sellForm 144 (planned sale)
Indexed to 100, dividend-adjusted, not a price chart.
When a name files heavily, the largest trades are drawn first.
Who owns CGNX: institutional holders (13F)
13F holdings, latest reported quarter
15,991,755 sh
$1.2B
10,099,866 sh
$731.4M
8,206,627 sh
$594.3M
7,509,391 sh
$543.8M
5,829,878 sh
$422.0M
Congress trades in CGNX
No Congress trades reported
No House member has disclosed a trade in this stock. See what Congress is buying.
Activist and 5% holders (13D/13G)
No 5%+ ownership filings
Nobody has filed for crossing 5%. That is a fact, not missing data.
CGNX planned insider sales (Form 144)
Notice of intent to sell, filed before any sale
MATTHEW MOSCHNER
Filed 2026-08-11
$1.6M
Willett Robert
Filed 2026-06-30
$12.3M
Willett Robert
Filed 2026-06-29
$596.1K
CGNX mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
Tarkio Fund
$28.9M position · as of 2026-05-31
11.2%
Tema U.S. Manufacturing & Reshoring ETF
$20.9M position · as of 2026-05-31
7.6%
Brown Capital Management Small Company Fund
$18.8M position · as of 2026-06-30
5.9%
The Disciplined Growth Investors Equity Fund
$8.9M position · as of 2026-07-31
5.1%
TCW Transform Supply Chain ETF
$608.2K position · as of 2026-07-31
5.1%
Mairs & Power Small Cap Fund
$10.7M position · as of 2026-06-30
4.0%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Executive pay vs shareholder return · Robert J. Willett
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2020
$3.5M
$10.8M
$3.2M
+52%
+40%
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders have filed to sell, before selling.
The record shows a net $16.6M sold by insiders over 180 days, 401 funds added last quarter, $1.6M in planned Form 144 sales. Each figure is a federal filing, dated the day it went public.
CGNX financials
Revenue growth
+8.7%
XBRL, annual
Net margin
11.5%
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$1.1B
four quarters, 2025-06-30 to 2026-07-05
Revenue, TTM CGNX
| FY Dec 2025 | $994.4M |
| FY Dec 2024 | $914.5M |
| FY Sep 2024 | $881.5M |
| FY Dec 2023 | $837.5M |
| FY Oct 2023 | $880.3M |
| Jul 2026 | $291.3M |
| Apr 2026 | $268.4M |
| Dec 2025 | $252.3M |
| Sep 2025 | $276.9M |
| Jun 2025 | $249.1M |
| Mar 2025 | $216.0M |
| Dec 2024 | $229.7M |
| Sep 2024 | $234.7M |
At each fiscal year end
Single quarter
Net margin, TTM
+16.1%
net income over revenue, 2025-06-30 to 2026-07-05
Net margin, TTM CGNX
| FY Dec 2025 | +11.5% |
| FY Dec 2024 | +11.6% |
| FY Sep 2024 | +10.1% |
| FY Dec 2023 | +13.5% |
| FY Oct 2023 | +17.9% |
| Jul 2026 | +25.0% |
| Apr 2026 | +19.3% |
| Dec 2025 | +12.9% |
| Sep 2025 | +6.4% |
| Jun 2025 | +16.3% |
| Mar 2025 | +10.9% |
| Dec 2024 | +12.3% |
| Sep 2024 | +12.6% |
At each fiscal year end
Single quarter
Free cash flow, TTM
$268.3M
operating cash flow minus capex, 2025-06-30 to 2026-07-05
Free cash flow, TTM CGNX
| FY Dec 2025 | $236.8M |
| FY Dec 2024 | $134.0M |
| FY Sep 2024 | $92.2M |
| FY Dec 2023 | $89.8M |
| FY Oct 2023 | $144.6M |
| Jul 2026 | $67.6M |
| Apr 2026 | $42.3M |
| Dec 2025 | $72.3M |
| Sep 2025 | $86.0M |
| Jun 2025 | $40.4M |
| Mar 2025 | $38.0M |
| Dec 2024 | $49.3M |
| Sep 2024 | $51.9M |
At each fiscal year end
Single quarter
Debt to equity
n/a
no debt line filed
Debt to equity CGNX
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Sep 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Oct 2023 | n/a |
| Jul 2026 | n/a |
| Apr 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
n/a
no debt line filed
Cash flow to debt CGNX
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Sep 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Oct 2023 | n/a |
| Jul 2026 | n/a |
| Apr 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+11.1%
TTM net income over average of 2025-06-29 and 2026-07-05
Return on equity CGNX
| FY Dec 2025 | +7.6% |
| FY Dec 2024 | +7.0% |
| FY Sep 2024 | +5.8% |
| FY Dec 2023 | +7.7% |
| FY Oct 2023 | +10.9% |
| Jul 2026 | +11.1% |
| Apr 2026 | +9.7% |
| Dec 2025 | +7.6% |
| Sep 2025 | +7.2% |
| Jun 2025 | +8.1% |
| Mar 2025 | +8.0% |
| Dec 2024 | +7.0% |
| Sep 2024 | +5.8% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+8.4%
TTM net income over average of 2025-06-29 and 2026-07-05
Return on assets CGNX
| FY Dec 2025 | +5.7% |
| FY Dec 2024 | +5.3% |
| FY Sep 2024 | +4.4% |
| FY Dec 2023 | +5.7% |
| FY Oct 2023 | +8.1% |
| Jul 2026 | +8.4% |
| Apr 2026 | +7.2% |
| Dec 2025 | +5.7% |
| Sep 2025 | +5.4% |
| Jun 2025 | +6.1% |
| Mar 2025 | +6.0% |
| Dec 2024 | +5.3% |
| Sep 2024 | +4.4% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
no debt line filed
Return on invested capital CGNX
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Sep 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Oct 2023 | n/a |
| Jul 2026 | n/a |
| Apr 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
+12.6%
operating income (EBIT proxy) over average of 2025-06-29 and 2026-07-05 minus current liabilities
Return on capital employed CGNX
| FY Dec 2025 | +8.9% |
| FY Dec 2024 | +6.2% |
| FY Sep 2024 | +5.2% |
| FY Dec 2023 | +7.2% |
| FY Oct 2023 | +9.7% |
| Jul 2026 | +12.6% |
| Apr 2026 | +11.0% |
| Dec 2025 | +8.9% |
| Sep 2025 | +8.5% |
| Jun 2025 | +7.2% |
| Mar 2025 | +7.1% |
| Dec 2024 | +6.2% |
| Sep 2024 | +5.2% |
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
53.49x
close 2026-10-26 over four quarters of diluted EPS, 2025-06-30 to 2026-07-05
P/E, trailing CGNX
| FY Dec 2025 | 52.91x |
| FY Dec 2024 | 57.84x |
| FY Sep 2024 | 78.96x |
| FY Dec 2023 | 64.22x |
| FY Oct 2023 | 46.64x |
| Jul 2026 | 65.19x |
| Apr 2026 | 57.85x |
| Dec 2025 | 52.91x |
| Sep 2025 | 70.45x |
| Jun 2025 | 43.69x |
| Mar 2025 | 43.49x |
| Dec 2024 | 57.84x |
| Sep 2024 | 78.96x |
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
n/a
no debt line filed
Enterprise value CGNX
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Sep 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Oct 2023 | n/a |
| Jul 2026 | n/a |
| Apr 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
+2.9%
TTM free cash flow over market value at close 2026-10-26
FCF yield CGNX
| FY Dec 2025 | +3.9% |
| FY Dec 2024 | +2.2% |
| FY Sep 2024 | +1.3% |
| FY Dec 2023 | +1.3% |
| FY Oct 2023 | +2.0% |
| Jul 2026 | +2.4% |
| Apr 2026 | +3.0% |
| Dec 2025 | +3.9% |
| Sep 2025 | +2.8% |
| Jun 2025 | +3.4% |
| Mar 2025 | +3.2% |
| Dec 2024 | +2.2% |
| Sep 2024 | +1.3% |
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
1.20x
P/E over trailing EPS growth of 44%: four quarters to 2026-07-05 against the four to 2025-06-29
PEG, trailing CGNX
| FY Dec 2025 | 5.47x |
| FY Dec 2024 | n/a |
| FY Sep 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Oct 2023 | n/a |
| Jul 2026 | 1.47x |
| Apr 2026 | 2.49x |
| Dec 2025 | 5.47x |
| Sep 2025 | 2.57x |
| Jun 2025 | 0.73x |
| Mar 2025 | 2.07x |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-26. Hover or tap a tile for its yearly and quarterly history.
Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
| 2025-12 | 2024-12 | 2024-09 | 2023-12 | |
|---|---|---|---|---|
| Revenue | $994.4M | $914.5M | n/a | $837.5M |
| Gross profit | $665.4M | $625.8M | n/a | $601.2M |
| Operating income | $162.6M | $115.1M | n/a | $130.7M |
| Net income | $114.4M | $106.2M | n/a | $113.2M |
| EPS (diluted) | 0.68 | 0.62 | n/a | 0.65 |
| Operating cash flow | $245.5M | $149.1M | n/a | $112.9M |
| Cash | $262.9M | $186.1M | $197.1M | $202.7M |
| Buybacks | $151.2M | $67.1M | n/a | $79.8M |
| Dividends paid | $54.6M | $52.3M | n/a | $49.1M |
SEC XBRL, fiscal years, as known on 2026-10-28
CGNX Stock Sonar score 5/7 axes
Find similar shapesCompareCGNX ranks highest on institutional and government (83rd percentile) and profitability (67th), and lowest on insider conviction (8th), among Industrials peers.
5 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
CGNX filings, in plain words
Are Cognex insiders buying or selling CGNX?
In the 180 days to 2026-10-28, Cognex insiders were net sellers, a net $16.6M across purchases and sales reported on Form 4, by 4 sellers.
Are there planned insider sales of CGNX?
Yes. 1 Form 144 notice of planned insider sales was filed in the 90 days to 2026-10-28, covering $1.6M of stock; the latest, by MATTHEW MOSCHNER, was filed 2026-08-11.
Read the full summary
In the 180 days to 2026-10-28, Cognex insiders were net sellers of CGNX, a net $16.6M across purchases and sales reported on Form 4 by 4 sellers. None of the 26 insider sales was flagged as made under a Rule 10b5-1 plan. Insiders filed 1 Form 144 notice of intent to sell in the 90 days to 2026-10-28, covering $1.6M of stock. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
